Prokidney (PROK) Net Margin (2024 - 2026)

Prokidney (PROK) reported Net Margin of 18858.85% for Q1 2026, down 235798.0% year-over-year from N/an in Q1 2025, and down 3.87% on a QoQ basis from 18156.44% in Q4 2025.

Prokidney (PROK) has 3 years of Net Margin data on file, last reported at 18858.85% in Q1 2026.

  • Quarterly Net Margin fell 235798.0% year-over-year to 18858.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17579.42% (up 3665392.0% YoY) and the FY2025 annual result came in at 7725.2%, up 7278270.0% from the prior year.
  • Net Margin retreated to 18858.85% in Q1 2026 per PROK's latest filing, from 18156.44% in the prior quarter.
  • Across five years, Net Margin topped out at 16500.87% in Q1 2025 and bottomed at 63793.42% in Q4 2024.
  • The 3-year median for Net Margin is 17441.34% (2025), against an average of 25092.22%.
  • The widest annual swing landed in 2025, when Net Margin soared 4563698 bps; it then sank 235798 bps in 2026.
  • Tracing PROK's Net Margin over 3 years: stood at 63793.42% in 2024, then jumped by 72 bps to 18156.44% in 2025, then retreated by 4 bps to 18858.85% in 2026.
  • Per Business Quant, the three latest PROK Net Margin figures stand at 18858.85% (Q1 2026), 18156.44% (Q4 2025), and 16517.51% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 34.53%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 17.65%
10 Prokidney 259.72 Mn 1.55 Bn - -18,858.85%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18,858.85%
Dec 31, 2025 -18,156.44%
Sep 30, 2025 -16,517.51%
Jun 30, 2025 -16,726.24%
Mar 31, 2025 -16,500.87%
Dec 31, 2024 -63,793.42%